(Q43225410)

16 November 2017

Metabolic syndrome and alanine aminotransferase: a global perspective from the NAVIGATOR screening population (English)

1 reference

16 November 2017

1 reference

1 reference

6

R M Califf

1 reference

16 November 2017

7

S M Haffner

1 reference

16 November 2017

NAVIGATOR Study Group

9

object named as

NAVIGATOR Study Group

1 reference

16 November 2017

M A Bethel

1

1 reference

16 November 2017

P Deedwania

2

1 reference

16 November 2017

N S Levitt

3

1 reference

16 November 2017

O Schmitz

4

1 reference

16 November 2017

A Huntsman-Labed

5

1 reference

16 November 2017

P Diem

8

1 reference

16 November 2017

1 December 2009

1 reference

16 November 2017

1 reference

16 November 2017

26

1 reference

16 November 2017

12

1 reference

16 November 2017

1204-1211

1 reference

Non-alcoholic fatty liver syndrome: a hepatic consequence of common metabolic diseases

16 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02864.X

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02864.X

Review: The role of insulin resistance in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02864.X

Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02864.X

The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02864.X

Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02864.X

Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02864.X

Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02864.X

Unexplained elevations in alanine aminotransferase in individuals with the metabolic syndrome: results from the third National Health and Nutrition Survey (NHANES III).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02864.X

Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02864.X

Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02864.X

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02864.X

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02864.X

(Mis)use of factor analysis in the study of insulin resistance syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02864.X

Aminotransferase and gamma-glutamyltranspeptidase levels in obesity are associated with insulin resistance and the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02864.X

Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02864.X

Persistent elevation of liver function enzymes within the reference range is associated with increased cardiovascular risk in young adults: the Bogalusa Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02864.X

High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02864.X

Metabolic syndrome and NASH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02864.X

Alanine aminotransferase and directly measured insulin sensitivity in a multiethnic cohort: the Insulin Resistance Atherosclerosis Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02864.X

Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02864.X

Is obesity a risk factor for cirrhosis-related death or hospitalization? A population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02864.X

Adiponectin and Metabolic Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02864.X

Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02864.X

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02864.X

Study of genetic prediabetic south Indian subjects. Importance of hyperinsulinemia and beta-cell dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02864.X

Risk factors for the development of NIDDM in Yonchon County, Korea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02864.X

Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM. 5-Year follow-up of initially nondiabetic Japanese-American men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02864.X

What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02864.X

Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02864.X

Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02864.X

Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02864.X

Asian perspectives on viral hepatitis: hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02864.X

Clinical expression of insulin resistance in hepatitis C and B virus-related chronic hepatitis: differences and similarities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02864.X

Hepatitis C virus core protein upregulates serine phosphorylation of insulin receptor substrate-1 and impairs the downstream akt/protein kinase B signaling pathway for insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02864.X

Should Central Obesity Be an Optional or Essential Component of the Metabolic Syndrome?: Ischemic heart disease risk in the Singapore Cardiovascular Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02864.X

10.1111/J.1464-5491.2009.02864.X

21 January 2018

Identifiers

DOI

1 reference

16 November 2017

1 reference